CK Life Sciences International Holdings (FRA:LSI) EV-to-Revenue : 1.75 (As of May. 05, 2024)

View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CK Life Sciences International Holdings's enterprise value is €1,096.8 Mil. CK Life Sciences International Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €626.1 Mil. Therefore, CK Life Sciences International Holdings's EV-to-Revenue for today is 1.75.

The historical rank and industry rank for CK Life Sciences International Holdings's EV-to-Revenue or its related term are showing as below:

FRA:LSI' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.42 Med: 2.12 Max: 3.04
Current: 1.73

During the past 13 years, the highest EV-to-Revenue of CK Life Sciences International Holdings was 3.04. The lowest was 1.42. And the median was 2.12.

FRA:LSI's EV-to-Revenue is ranked better than
82.05% of 1036 companies
in the Biotechnology industry
Industry Median: 7.98 vs FRA:LSI: 1.73

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-05), CK Life Sciences International Holdings's stock price is €0.0425. CK Life Sciences International Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.07. Therefore, CK Life Sciences International Holdings's PS Ratio for today is 0.64.

CK Life Sciences International Holdings EV-to-Revenue Historical Data

The historical data trend for CK Life Sciences International Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings EV-to-Revenue Chart

CK Life Sciences International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

2.67

2.79

2.30

2.43

2.11

CK Life Sciences International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															2.30	-	2.43	-	2.11

Competitive Comparison of CK Life Sciences International Holdings's EV-to-Revenue

For the Biotechnology subindustry, CK Life Sciences International Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CK Life Sciences International Holdings's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's EV-to-Revenue falls into.

CK Life Sciences International Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

CK Life Sciences International Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	1096.754	/	626.056
	=	1.75

CK Life Sciences International Holdings's current Enterprise Value is €1,096.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CK Life Sciences International Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €626.1 Mil.

CK Life Sciences International Holdings (FRA:LSI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

CK Life Sciences International Holdings's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.0425	/	0.066
	=	0.64

CK Life Sciences International Holdings's share price for today is €0.0425.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.07.

CK Life Sciences International Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

CK Life Sciences International Holdings (FRA:LSI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (FRA:LSI) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

00775:Hong Kong

Address

2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG

Website

https://www.ck-lifesciences.com

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.